Communiqués CalciMedica, Inc. OTC Markets

Actions

CALC

US38942Q2021

Marché Fermé - OTC Markets Autres places de cotation 22:30:01 16/07/2024			Varia. 5j.	Varia. 1 janv.
4,88 ^USD	+1,46%		+9,91%	+70,63%

09/07	CalciMedica annonce que la première personne a reçu une dose dans le cadre de l'essai de phase 2 d'Auxora pour le traitement des lésions rénales aiguës	MT
09/07	CalciMedica Inc. annonce le recrutement du premier patient dans l'essai de phase 2 KOURAGE d'Auxora ? pour le traitement des lésions rénales aiguës sévères	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury	10/07	AQ
CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)	09/07	PR
CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences	08/07	PR
CalciMedica Set to Join Russell Microcap Index	02/07	AQ
CalciMedica Set to Join Russell Microcap® Index	01/07	PR
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis	28/06	AQ
CalciMedica : CARPO Trial Topline Results presentation	27/06	PU
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)	27/06	PR
CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)	26/06	PR
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates	13/05	PR
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis	25/04	AQ
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis	24/04	PR
CalciMedica : Material Event - Form 8-K	29/03	PU
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference	13/03	PR
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI and CRRT Conference	29/02	AQ
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference	29/02	PR
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury	14/02	AQ
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury	13/02	PR
CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	07/02	PR
CalciMedica Announces Private Placement of up to Approximately $55 Million	22/01	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués CalciMedica, Inc. OTC Markets

Actions

CALC

US38942Q2021

Communiqués

Filtres